Tennessee § 63-6-303 Manufacturer permitted to provide investigational drug, biological product, or device to eligible patient - Conditions

Tennessee Statutes

§ 63-6-303 — Manufacturer permitted to provide investigational drug, biological product, or device to eligible patient - Conditions

Tennessee § 63-6-303

Title63

This text of Tennessee § 63-6-303 (Manufacturer permitted to provide investigational drug, biological product, or device to eligible patient - Conditions) is published on Counsel Stack Legal Research, covering Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tenn. Code Ann. § 63-6-303 (2026).

Text

(a)A manufacturer of an investigational drug, biological product, or device may make available, and an eligible patient may request, the manufacturer's investigational drug, biological product, or device under this part; provided, that this part does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.

(b)A manufacturer may do all of the following:

(1)Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation; and (2) Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.

Free access — add to your briefcase to read the full text and ask questions with AI

(a) A manufacturer of an investigational drug, biological product, or device may make available, and an eligible patient may request, the manufacturer's investigational drug, biological product, or device under this part; provided, that this part does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient. (b) A manufacturer may do all of the following: (1) Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation; and (2) Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.